|
KIAA0494 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.398250E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.211000E-04 |
| Normal-vs-Stage2 |
4.096300E-02 |
| Normal-vs-Stage3 |
6.34330000000016E-05 |
| Normal-vs-Stage4 |
1.169290E-04 |
| Stage1-vs-Stage2 |
5.801600E-01 |
| Stage1-vs-Stage3 |
2.295800E-01 |
| Stage1-vs-Stage4 |
2.448600E-01 |
| Stage2-vs-Stage3 |
2.003600E-01 |
| Stage2-vs-Stage4 |
1.891580E-01 |
| Stage3-vs-Stage4 |
8.177800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.41959999999608E-05 |
| Normal-vs-AfricanAmerican |
1.910000E-01 |
| Normal-vs-Asian |
6.594400E-04 |
| Caucasian-vs-AfricanAmerican |
1.940550E-01 |
| Caucasian-vs-Asian |
7.564400E-01 |
| AfricanAmerican-vs-Asian |
1.669180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.021280E-04 |
| Normal-vs-Female |
4.197500E-04 |
| Male-vs-Female |
4.570800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.562300E-04 |
| Normal-vs-Age(41-60Yrs) |
5.448500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.220550E-03 |
| Normal-vs-Age(81-100Yrs) |
1.619610E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.782600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.820000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.576200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.702600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.332200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.414000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.039700E-03 |
| Classical-VS-Follicular |
2.051200E-01 |
| Classical-VS-Other |
1.254180E-01 |
| Classical-VS-Normal |
3.324100E-03 |
| Tall-VS-Follicular |
1.573170E-01 |
| Tall-VS-Other |
6.046000E-01 |
| Tall-VS-Normal |
2.395299999991E-05 |
| Follicular-VS-Other |
3.064800E-01 |
| Follicular-VS-Normal |
1.236080E-03 |
| Other-VS-Normal |
9.396200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.021090E-03 |
| Normal-vs-N1 |
4.05960000005035E-06 |
| N0-vs-N1 |
7.362300E-02 |
|
|
